Quarterly Report • Jul 25, 2022
Quarterly Report
Open in ViewerOpens in native device viewer
Exchange House Primrose Street London EC2A 2NY
020 7628 8000
fandc.com
Computershare Investor Services PLC The Pavilions, Bridgwater Road Bristol BS99 6ZZ
0800 923 1506
computershare.com
© 2022 Columbia Threadneedle Investments. Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies.
FOR THE SIX MONTHS ENDED 30 JUNE 2022
F&C Investment Trust PLC ('FCIT' or the 'Company') was founded in 1868 as the first investment trust with the purpose of providing the investor of more moderate means access to the same opportunities and advantages as the very largest investors.
This purpose continues today, providing a foundation for the long-term investment needs of large and small investors through a diversified, convenient and cost effective global investment choice.
Our objective is to achieve long-term growth in capital and income through a policy of investing primarily in an internationally diversified portfolio of publicly listed equities, as well as unlisted securities and private equity, combined with the use of gearing.
Our approach is designed to obtain the investment performance benefits from a range of individually concentrated global and regional portfolios alongside the diversification benefits of lower risk and lower volatility achieved by managing these portfolios in combination. Offering a globally diversified portfolio of growth assets, the Company aims to be a core investment choice through all available channels.
The Company continues to evolve, allowing it to keep pace with new investment opportunities and maintain its relevance in today's world. We believe in the power of engaged, long-term ownership as a force for positive change and we have a Manager that applies high standards of Responsible Investment in managing the investments on behalf of our shareholders. A commitment has been made to transition the Company's portfolio to net zero carbon emissions by 2050, at the latest.
The Company is suitable for retail investors in the UK, professionally advised private clients and institutional investors who seek growth in capital and income from investment in global markets and who understand and are willing to accept the risks, as well as the rewards, of exposure to equities.
The Company is registered in England and Wales with company registration number 12901 Legal Entity Identifier: 213800W6B18ZHTNG7371
Potential investors are reminded that the value of investments and the income from dividends may go down as well as up and investors may not receive back the full amount invested. Tax benefits may vary as a result of statutory changes and their value will depend on individual circumstances.
This document may contain forward-looking statements with respect to the financial condition, results of operations and business of the Company. Such statements involve risk and uncertainty because they relate to future events and circumstances that could cause actual results to differ materially from those expressed or implied by forward-looking statements. The forward-looking statements are based on the Directors' current view and on information known to them at the date of this document. Nothing should be construed as a profit forecast.
Our share price total return(1) -11.8% was -11.8%
Our Net Asset Value total return(1),(2) was -9.6%, which was ahead of the return from our benchmark, FTSE All-World Index, of -10.7%
Our Revenue Reserve has enabled us to withstand many an economic downturn, including the Global Financial Crisis, and holds us in very good stead in continuing to deliver growth in dividends for our shareholders. It is a unique advantage, amongst others, which investment trust companies hold over open ended funds. The Board is therefore committed to a further rise in our dividend this year, which will be the 52nd consecutive rise in total dividend for shareholders.
(1) Total return – return to shareholders calculated on a per share basis by adding dividends paid in the period to the increase or decrease in the share price or Net Asset Value in the period*
(2) Including debt at market value. Represents the replacement value of debt, assuming repaid and re-negotiated under current market conditions*
*See full details of the explanation and calculation of Alternative Performance Measures in the Report and Accounts as at 31 December 2021
"WHILE WE EXPECT THAT THE IMMEDIATE OUTLOOK WILL CONTINUE TO PRESENT A CHALLENGE, OUR PORTFOLIO IS SUFFICIENTLY DIVERSIFIED TO PROVIDE PROTECTION FROM OVER-EXPOSURE TO ANY ONE THEME THAT IS DRIVING MARKETS."
A substantial rise in inflation, caused by sharply rising energy prices after Russia's invasion of Ukraine, coupled with post-Covid supply chain issues led to expectations for a tightening of monetary policy by central banks globally, a consequent decrease in risk appetite and sharp falls in equity markets worldwide. Rising commodity prices more generally added impetus to the surge in inflation which, contrary to the consensus, has not been transitory and has remained at stubbornly high levels. With equities declining into a 'bear market', defined as a fall from the peak of over 20%, the Company delivered a Net Asset Value ('NAV') total return of -9.6%,
whilst our benchmark, the FTSE All-World Index, fell by 10.7%. However, a widening in the Company's discount from 7.3% to 9.6%, meant that the shareholder total return was -11.8%.
The NAV per share closed at 892.8 pence compared with 998.7 pence at the end of 2021. The return from our underlying investment portfolio was marginally behind the return of the benchmark. Despite holding a geared position, which detracted 1.0% from returns, a rise in longer-dated market interest rates reduced the fair value of our debt, and this added 2.5% to our NAV return.
We started the year with a gearing level of 9.4% and ended the first half with 6.5% gearing. During the period we drew £140m of additional long dated borrowings through long-term private placement loans.
Valuations in the private equity part of the portfolio have so far held up well and delivered a return of 4.7% over the first six months, however we expect these to come under pressure as the year progresses to reflect what has happened in the public markets. We have continued to make selective investments in this area and agreed a new programme of exposure in leading growth and venture managers which will be managed by Pantheon. These commitments are long-term in nature and our experience in terms of unlisted private equity exposure has, historically, been positive.
We paid a third interim dividend of 3.0 pence per share for the year ended 31 December 2021 in February 2022 and a final dividend of 3.8 pence in May. We drew down 1.7 pence per share from our revenue reserve to help fund the full year dividend of 12.8 pence. This represented an increase of 5.8% on the previous year, ahead of the 5.4% rise in inflation for the year to 31 December 2021.
We continued to see good progress in our net revenue return over the first six months of the year, which rose by 27.6% to 7.48p in comparison to 5.86p over the same period last year. The decline in sterling had a positive impact, increasing returns by £1.1m (in the 2021 half year there was a negative impact of £2.2m). Special dividends totalled £1.0m, up slightly from £0.6m in the first half of 2021. We have declared a first interim dividend for the current year of 3.2 pence per share payable on 1 August 2022.
Despite a strong recovery from the pandemic, there remains significant uncertainty with respect to our full year income but, at this point, it is unlikely that our earnings will cover the full year dividend payment to shareholders. Therefore, as was the case in 2021, we expect to fund a proportion of the annual payment from our Revenue Reserve, which continues to represent over one year's worth of annual dividends. The Board intends to increase dividends in real terms for shareholders over the long-term and our current aim is to raise our dividend again this year. If we do so, this will be the 52nd consecutive rise.
Jeff Hewitt retired from the Board at the conclusion of the AGM in May this year, after 11 years' service as a Director and 10 years as Chairman of our Audit Committee. I am delighted that Julie Tankard will replace Jeff and she joins the Board with effect from 1 August 2022. Julie is the Chief Financial Officer and a Board member of the Port of London, where she is also responsible for risk. She is a fellow of the Chartered Institute of Management Accountants. Julie sits on the Industrial Development Advisory Board and previously chaired the audit committee of an NHS Foundation Trust, prior to which she held various senior positions at BT plc.
The rise in inflation seen thus far and fears that we may be entering a period where price pressures will remain elevated is causing substantial concern for both individuals and market participants. Interest rate expectations have risen and valuations in equity markets have fallen as investors grow increasingly nervous that a recession may be imminent.
The balance of risks suggests that investors are right to position for a fundamentally different, and potentially more challenging, backdrop. Markets have, however, already reflected changed expectations and much of the speculative froth has been removed from market pricing. A more reasonable valuation backdrop presents opportunities for investors with a longer time horizon and a patient approach to investing. While we expect that the immediate outlook will continue to present a challenge, our portfolio is sufficiently diversified to provide protection from over-exposure to any one theme that is driving markets. As noted earlier, our gearing levels have been reduced and our Manager has tilted the portfolio towards areas more likely to benefit from a change in the investment landscape.
Beatrice Hollond Chairman 22 July 2022
It has been a difficult period for financial markets so far in 2022 with a substantial rise in market interest rates, reflecting concerns over the outlook for inflation, a widening in credit spreads, due to concerns over an economic slowdown and increased risk of corporate defaults, and sharp falls in equity markets.
Inflation and growth concerns, exacerbated by the conflict in Ukraine, were key themes over the first half of the year. Inflation continued to accelerate across many different regions, reaching the highest levels seen in the US for 40 years. With the exception of Japan, most major developed market central banks have now begun increasing interest rates or indicated their intention to do so. This pivot from central banks has led to a marked rotation away from highly rated growth stocks towards the value segments of the market. Despite the steps taken so far, pressure remains to curb persistent inflation. Indeed, inflation has proven less transient than many initially thought, as markets continue to price in
further monetary tightening and are now increasingly contemplating a recession in the US and other developed market economies.
Currency markets also saw significant volatility. Sterling fell sharply against the US dollar, from 1.35 to 1.22, while the yen declined to a greater than twenty-year low against the US dollar, driven by ongoing loose monetary policy against a backdrop of rising global interest rates.
Our investment portfolio delivered a return of -10.8% compared to the market benchmark return of -10.7%. In terms of exposure, all listed equity regions lost value, with our North American equity holdings, our largest regional allocation, falling 12.1%. 'Growth' stocks had a torrid time and substantially underperformed cheaper 'value' exposure. As investors priced in the prospect of higher inflation and interest rates and grew concerned over large scale withdrawal of liquidity by central banks, the valuation premium on more expensive segments of the market, including disruptive
technology stocks, diminished. More speculative equity investments, trading on high valuations and with little or no profits, were hit particularly hard and investors sought safety in more lowly valued stocks with greater visibility in near term earnings.
We have made substantial reductions in terms of our exposure to more expensive parts of the equity market, predominantly through the sale of US large cap growth stocks, starting in the second half of 2020 and through the course of 2021. During the first half of this year we made further sales in expectation of underperformance in this area. In addition, we made the decision to divest entirely from our exposure to Global Small Cap stocks, having initially reduced our holdings last year. In our view, small cap stocks are less likely to perform well in an environment of rising inflation and we decided to focus our exposure on the large cap space. Small cap holdings modestly underperformed over the first half.
We increased our allocation to higher yielding stocks, expecting better performance to be driven by relative valuations from this area but the primary destination for the proceeds of our sales was cash. Indeed, we
raised cash levels by almost £300m, from £53m at the start of the year to £352m at the end of June. Some of this increase reflects the funding of our £140m private placement notes and we will use some of the proceeds to pay down a seven-year Euro denominated loan of €72m in July. Nonetheless, the effect of our allocation changes was to reduce our net gearing levels to 6.5% with debt at par and 4.3% when we adjust for the fair value of our debt.
As well as reducing our gearing levels and making further re-allocations away from US large cap growth stocks, we reduced the outstanding value of our sterling hedge from around £200m to under £30m, with a view to benefitting from sterling weakness. While rates rose in the UK and inflation here reached the highest amongst G7 nations, we saw limited upside potential for the domestic currency.
Within our US holdings it was our value manager Barrow Hanley (-0.6% return) which provided the best returns, while the strategy managed by our US growth manager T Rowe Price posted a loss of -25.8%. Energy and commodity related stocks such as Hess (+60.8%), Pioneer Natural Resources (+42.7%) and Phillips 66 (+28.9%) were amongst the
top performers in the US while a number of our large holdings, such as Meta (-46%) and Amazon (-28.9%), detracted from returns.
Within our Global Strategies (-11.9% return) there was a wide dispersion of performance. Strongest returns came from our Quality Income strategy (-1.4%) where Woodside Petroleum (+61.4%) and Computershare (+31.3%) helped relative returns. Despite delivering a loss of 6.1%, our higher yielding Global Income strategy, where we invest in companies which have attractive yield characteristics and which tend to trade at a valuation discount, produced strong relative returns against a weak
overall market backdrop. Elsewhere, our exposure to Sustainable Opportunities performed poorly, delivering a return of -19.6%. As was the case elsewhere, the weighting in energy and commodity related stocks, along with more defensive areas of the market such as consumer staples and utilities, played a role in relative returns. Indeed, oil and gas stocks were the strongest performing area over the six months, delivering a gain of 28.0% as, in response to the war in Ukraine and concerns over disruption to global supply as well as an improved demand picture, crude oil gained up to \$45 a barrel, having started the year at around \$75 a barrel.
| Contributors to total return in first half of 2022 (%) | |
|---|---|
| -------------------------------------------------------- | -- |
| Portfolio return | -10.8 |
|---|---|
| Management fees | -0.2 |
| Interest and other expenses | -0.2 |
| Buybacks | 0.1 |
| Change in value of debt | 2.5 |
| Gearing/other | -1.0 |
| Net asset value total return* | -9.6 |
| Change in rating | -2.2 |
| Share price total return | -11.8 |
| FTSE All World Total Return | -10.7 |
| *Debt at market value |
Source: Columbia Threadneedle/State Street
| Investment portfolio strategy |
Our portfolio strategy weighting % |
Underlying geographic exposure* |
Benchmark weighting % |
Our strategy performance in sterling % |
Index performance in sterling % |
|---|---|---|---|---|---|
| North America |
39.6 | 57.1 | 61.8 | -12.1 | -11.6 |
| Europe inc UK |
10.8 | 23.8 | 16.0 | -13.8 | -12.2 |
| Japan | 4.6 | 6.9 | 6.3 | -16.8 | -10.2 |
| Emerging Markets |
7.2 | 8.4 | 11.0 | -12.5 | -8.1 |
| Developed Pacific |
– | 3.8 | 4.9 | – | -6.1 |
| Global Strategies |
24.8 | – | – | -11.9 | -10.7 |
| Private Equity |
13.0 | – | – | 4.7 | – |
*Represents the geographic exposure of the portfolio, including underlying exposures in private equity and fund holdings
Source: Columbia Threadneedle/State Street
In Europe inc. UK (-13.8%) our biggest positive contribution came from pharmaceuticals where an overweight stance to AstraZeneca (+26.6%), GlaxoSmithKline (+12.4%) and Novo Nordisk (+10.9%) benefited returns. Each produced good results and confident outlooks at a time when investors are increasingly concerned about weakening profitability. An underweight stance on oil and gas stocks and poor returns from both Delivery Hero
(-62.6%) and JustEat (-68.3%), however, detracted from returns. Holdings in low-cost airlines, including Wizz Air (-58.1%), also impacted negatively despite clear evidence of rising fares, as fuel costs continued to rise (though airports have cancelled many flights).
Japanese holdings underperformed both the local benchmark and the global index. The strategy suffered headwinds, with quality growth
stocks on relatively high multiples underperforming materially relative to value stocks, as expectations for higher global interest rates picked up. Lockdown thematic winners like Keyence (-39.2%) and Hoya (-35.7%) underperformed and, as was the case with some of our other managers, lack of exposure to energy and utility stocks was detrimental to returns.
Our private equity holdings had a strong first half, posting overall gains of 4.7%. Our recent commitments, where we hold 8.3% of the portfolio assets, posted strong returns of 7.9%, as did our older holdings overseen by Pantheon and HarbourVest which delivered a gain of 6.6%. Both returns were substantially ahead of listed markets. Elsewhere, we saw good progress on our Pantheon Future Growth allocation, which became fully committed and which invests into leading growth and venture managers. We have made a further \$180m commitment to a new and similar programme also managed by Pantheon. These, and other private equity holdings, are longterm in nature and, historically, we have enjoyed good returns against public market equivalents from such positions. More disappointing returns were delivered from our holdings in life sciences investor Syncona (-3.8%), and the Baillie Gifford managed
Schiehallion fund (-43.4%) which fell from a premium to a discount over the period.
A substantial rise in market interest rates led to a reduction in the fair value of our debt over the period. Indeed, with ten-year gilt yields rising from less than 1% at the start of the year to over 2.2% by the end of June, this shift in pricing added 2.5% to our NAV return over the six months. The impact of gearing in a declining market was -1.0%.
The current backdrop is challenging for the global economy and for financial markets. Investors are increasingly concerned that recession will hit major developed economies later this year and into 2023 as central bankers increase interest rates and rein in excess liquidity. In addition, inflation is proving more problematic than many had originally envisaged, raising questions over the level that interest rates will reach and how deep the growth downturn will be.
Having seen a substantial reduction in valuations in equities, led by more expensive parts of the market, and a significant change in expectations over interest rates, there is likely
to be greater investor focus on margins, cashflows and overall corporate earnings in the coming months. Here, consensus still seems reasonably optimistic. This presents some further near-term risk to equity markets. Nonetheless, and despite a period which is likely to continue to see further volatility in returns, opportunities are emerging. Valuations have corrected and are more attractive for long-term investors. While margins are at risk, equities will provide some hedge to inflation as corporates pass on price rises to consumers. With a relatively high holding of cash and diversified exposure across a range of different equity strategies we believe that the Company is appropriately positioned for the difficult market conditions that we expect. Given our longerterm perspective, we expect to be in a strong position to take advantage of investment opportunities as they emerge and to benefit from a recovery in equity markets in due course.
Paul Niven Fund Manager 22 July 2022
| 30 Jun 2022 |
31 Dec 2021 |
% of total investments |
Value £'000s |
|
|---|---|---|---|---|
| 1 | (1) | Microsoft | 2.2 | 107,322 |
| 2 | (2) | Alphabet | 2.0 | 95,355 |
| 3 | (6) | UnitedHealth | 1.9 | 92,174 |
| 4 | (4) | Apple | 1.8 | 85,114 |
| 5 | (3) | Amazon | 1.3 | 65,208 |
| 6 | (11) | Elevance Health (previously Anthem) | 1.0 | 50,690 |
| 7 | (9) | Dollar General | 1.0 | 46,335 |
| 8 | (18) | Merck | 0.9 | 41,447 |
| 9 | (7) | Taiwan Semiconductor Manufacturing (TSMC) |
0.8 | 40,218 |
| 10 | (20) | CVS | 0.8 | 38,877 |
| 30 Jun 2022 |
31 Dec 2021 |
% of total investments |
Value £'000s |
|
|---|---|---|---|---|
| 11 | (10) | International Flavors & Fragrances | 0.8 | 38,857 |
| 12 | (8) | Broadcom | 0.8 | 37,809 |
| 13 | (73) | AstraZeneca | 0.8 | 36,821 |
| 14 | – | VICI Properties | 0.7 | 35,372 |
| 15 | (37) | Hess | 0.7 | 34,586 |
| 16 | (30) | Wells Fargo | 0.7 | 34,028 |
| 17 | (49) | Phillips 66 | 0.7 | 32,630 |
| 18 | (12) | Tesla | 0.7 | 31,742 |
| 19 | (70) | GSK | 0.6 | 31,547 |
| 20 | (14) | Mastercard | 0.6 | 31,469 |
The value of the twenty largest listed equity holdings represents 20.8% (31 December 2021: 20.6%) of the Company's total investments. The figures in brackets denote the position at the previous year end.
These are the largest listed equity holdings excluding collective investment schemes. If the whole portfolio was considered then PE Investment Holdings 2018 LP (£209.1m), Inflexion Strategic Partners (£77.1m), Pantheon Access SICAV (£76.0m) and Vanguard FTSE 100 UCITS ETF (£35.1m) would have been included in the list.
| Half-year ended 30 June 2022 | Half-year ended 30 June 2021 | Year ended 31 December 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Notes | Revenue £'000s |
Capital £'000s |
Total £'000s |
Revenue £'000s |
Capital £'000s |
Total £'000s |
Revenue £'000s |
Capital £'000s |
Total £'000s |
| (Losses)/gains on investments and derivatives | – | (649,585) | (649,585) | – | 487,969 | 487,969 | – | 879,862 | 879,862 |
| Exchange gains/(losses) | 335 | (7,158) | (6,823) | (216) | 7,922 | 7,706 | (176) | 4,251 | 4,075 |
| 3 Income | 50,833 | – | 50,833 | 40,396 | – | 40,396 | 77,629 | – | 77,629 |
| 4 Fees and other expenses | (4,848) | (6,784) | (11,632) | (3,975) | (7,206) | (11,181) | (8,435) | (14,862) | (23,297) |
| Net return before finance costs and taxation | 46,320 | (663,527) | (617,207) | 36,205 | 488,685 | 524,890 | 69,018 | 869,251 | 938,269 |
| 4 Interest payable and similar charges | (1,751) | (5,255) | (7,006) | (1,221) | (3,663) | (4,884) | (2,778) | (8,335) | (11,113) |
| Net return on ordinary activities before taxation |
44,569 | (668,782) | (624,213) | 34,984 | 485,022 | 520,006 | 66,240 | 860,916 | 927,156 |
| 5 Taxation on ordinary activities | (5,373) | (551) | (5,924) | (3,630) | (138) | (3,768) | (7,740) | (138) | (7,878) |
| 6 Net return attributable to shareholders | 39,196 | (669,333) | (630,137) | 31,354 | 484,884 | 516,238 | 58,500 | 860,778 | 919,278 |
| 6 Net return per share – basic (pence) | 7.48 | (127.67) | (120.19) | 5.86 | 90.69 | 96.55 | 10.99 | 161.74 | 172.73 |
| Half-year ended 30 June 2022 | Half-year ended 30 June 2021 | Year ended 31 December 2021 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Revenue £'000s |
Capital £'000s |
Total £'000s |
Revenue £'000s |
Capital £'000s |
Total £'000s |
Revenue £'000s |
Capital £'000s |
Total £'000s |
|
| (Losses)/gains on investments and derivatives | – | (649,585) | (649,585) | – | 487,969 | 487,969 | – | 879,862 | 879,862 |
| Exchange gains/(losses) | 335 | (7,158) | (6,823) | (216) | 7,922 | 7,706 | (176) | 4,251 | 4,075 |
| 3 Income | 50,833 | – | 50,833 | 40,396 | – | 40,396 | 77,629 | – | 77,629 |
| 4 Fees and other expenses | (4,848) | (6,784) | (11,632) | (3,975) | (7,206) | (11,181) | (8,435) | (14,862) | (23,297) |
| Net return before finance costs and taxation | 46,320 | (663,527) | (617,207) | 36,205 | 488,685 | 524,890 | 69,018 | 869,251 | 938,269 |
| 4 Interest payable and similar charges | (1,751) | (5,255) | (7,006) | (1,221) | (3,663) | (4,884) | (2,778) | (8,335) | (11,113) |
| Net return on ordinary activities before taxation |
44,569 | (668,782) | (624,213) | 34,984 | 485,022 | 520,006 | 66,240 | 860,916 | 927,156 |
| 5 Taxation on ordinary activities | (5,373) | (551) | (5,924) | (3,630) | (138) | (3,768) | (7,740) | (138) | (7,878) |
| 6 Net return attributable to shareholders | 39,196 | (669,333) | (630,137) | 31,354 | 484,884 | 516,238 | 58,500 | 860,778 | 919,278 |
| 6 Net return per share – basic (pence) | 7.48 | (127.67) | (120.19) | 5.86 | 90.69 | 96.55 | 10.99 | 161.74 | 172.73 |
The total column is the profit and loss account of the Company.
All revenue and capital items in the above statement derive from continuing operations.
| Share | redemption | Capital | Revenue | shareholders' | |
|---|---|---|---|---|---|
| Notes | capital | reserve | reserves | reserve | funds |
| Half-year ended 30 June 2022 | £'000s | £'000s | £'000s | £'000s | £'000s |
| Balance brought forward 31 December 2021 | 140,455 | 122,307 | 4,924,320 | 93,852 | 5,280,934 |
| Movements during the half-year ended 30 June 2022 | |||||
| 11 Shares repurchased by the Company and held in treasury | – | – | (54,352) | – | (54,352) |
| 7 Dividends paid | – | – | – | (52,382) | (52,382) |
| Return attributable to shareholders | – | – | (669,333) | 39,196 | (630,137) |
| Balance carried forward 30 June 2022 | 140,455 | 122,307 | 4,200,635 | 80,666 | 4,544,063 |
| Half–year ended 30 June 2021 | |||||
| Balance brought forward 31 December 2020 | 140,455 | 122,307 | 4,147,868 | 100,930 | 4,511,560 |
| Movements during the half-year ended 30 June 2021 | |||||
| Shares repurchased by the Company and held in treasury | – | – | (34,059) | – | (34,059) |
| 7 Dividends paid | – | – | – | (33,709) | (33,709) |
| Return attributable to shareholders | – | – | 484,884 | 31,354 | 516,238 |
| Balance carried forward 30 June 2021 | 140,455 | 122,307 | 4,598,693 | 98,575 | 4,960,030 |
| Year ended 31 December 2021 | |||||
| Balance brought forward 31 December 2020 | 140,455 | 122,307 | 4,147,868 | 100,930 | 4,511,560 |
| Movements during the year ended 31 December 2021 | |||||
| Shares repurchased by the Company and held in treasury | – | – | (84,326) | – | (84,326) |
| 7 Dividends paid | – | – | – | (65,578) | (65,578) |
| Return attributable to shareholders | – | – | 860,778 | 58,500 | 919,278 |
| Balance carried forward 31 December 2021 | 140,455 | 122,307 | 4,924,320 | 93,852 | 5,280,934 |
| Total | Capital | ||
|---|---|---|---|
| shareholders' | Revenue | Capital | redemption |
| funds | reserve | reserves | reserve |
| £'000s | £'000s | £'000s | £'000s |
| 122,307 | 4,147,868 | 100,930 | 4,511,560 |
|---|---|---|---|
| $\overline{\phantom{a}}$ | (34,059) | $\overline{\phantom{a}}$ | (34, 059) |
| $\overline{\phantom{a}}$ | $\overline{\phantom{m}}$ | (33,709) | (33,709) |
| $\overline{\phantom{a}}$ | 484,884 | 31,354 | 516,238 |
| 122,307 | 4,598,693 | 98,575 | 4,960,030 |
| 4,511,560 | 100,930 | 4,147,868 | 122,307 |
|---|---|---|---|
| (84, 326) | $\overline{\phantom{a}}$ | (84, 326) | $\overline{\phantom{a}}$ |
| (65, 578) | (65, 578) | $\overline{\phantom{m}}$ | - |
| 919,278 | 58,500 | 860,778 | $\overline{\phantom{a}}$ |
| 5,280,934 | 93,852 | 4,924,320 | 122,307 |
| Notes | 30 June 2022 £'000s |
30 June 2021 £'000s |
31 December 2021 £'000s |
|
|---|---|---|---|---|
| Fixed Assets | ||||
| 8 Investments | 4,850,660 | 5,397,368 | 5,779,123 | |
| Current assets | ||||
| Debtors | 15,589 | 55,875 | 8,267 | |
| 14 Cash and cash equivalents | 352,290 | 54,903 | 53,111 | |
| Total current assets | 367,879 | 110,778 | 61,378 | |
| Creditors: amounts falling due within one year | ||||
| 9, 14 Loans | (61,981) | – | (110,452) | |
| 10 Other | (31,765) | (45,678) | (9,277) | |
| Total current liabilities | (93,746) | (45,678) | (119,729) | |
| Net current assets/(liabilities) | 274,133 | 65,100 | (58,351) | |
| Total assets less current liabilities | 5,124,793 | 5,462,468 | 5,720,772 | |
| Creditors: amounts falling due after more than one year |
||||
| 9, 14 Loans | (580,155) | (501,863) | (439,263) | |
| 9, 14 Debenture | (575) | (575) | (575) | |
| (580,730) | (502,438) | (439,838) | ||
| Net assets | 4,544,063 | 4,960,030 | 5,280,934 | |
| Capital and reserves | ||||
| 11 Share capital | 140,455 | 140,455 | 140,455 | |
| Capital redemption reserve | 122,307 | 122,307 | 122,307 | |
| Capital reserves | 4,200,635 | 4,598,693 | 4,924,320 | |
| Revenue reserve | 80,666 | 98,575 | 93,852 | |
| 12 Total shareholders' funds | 4,544,063 | 4,960,030 | 5,280,934 | |
| 12 Net asset value per ordinary share – prior charges at nominal value (pence) |
873.36 | 931.59 | 1,002.49 |
| Half-year | Half-year | Year | |
|---|---|---|---|
| ended | ended | ended | |
| 30 June | 30 June | 31 December | |
| 2022 £'000s |
2021 £'000s |
2021 £'000s |
|
| 13 Cash flows from operating activities before dividends received and interest paid |
(18,723) | (11,756) | (27,576) |
| Dividends received | 49,033 | 39,477 | 77,652 |
| Interest paid | (6,108) | (4,843) | (11,037) |
| Cash flows from operating activities | 24,202 | 22,878 | 39,039 |
| Investing activities | |||
| Purchases of Investments | (1,236,993) (1,322,861) (2,527,995) | ||
| Sales of Investments | 1,519,188 | 1,259,446 | 2,483,392 |
| Other capital charges and credits | (24) | (26) | (56) |
| Cash flows from investing activities | 282,171 | (63,441) | (44,659) |
| Cash flows before financing activities | 306,373 | (40,563) | (5,620) |
| Financing activities | |||
| Equity dividends paid | (35,733) | (33,709) | (65,578) |
| 14 Repayment of loans | (50,000) (100,000) | (120,000) | |
| 14 Drawdown of loans | 140,000 | 200,000 | 270,000 |
| Cash flows from share buybacks for treasury shares | (53,812) | (31,273) | (83,961) |
| Cash flows from financing activities | 455 | 35,018 | 461 |
| 14 Net increase/(decrease) in cash and cash equivalents | 306,828 | (5,545) | (5,159) |
| Cash and cash equivalents at the beginning of the period | 53,111 | 46,654 | 46,654 |
| 14 Effect of movement in foreign exchange | (7,649) | 13,794 | 11,616 |
| Cash and cash equivalents at the end of the period | 352,290 | 54,903 | 53,111 |
| Represented by: | |||
| Cash at bank | 219,657 | 24,711 | 27,798 |
| Short term deposits | 132,633 | 30,192 | 25,313 |
| 352,290 | 54,903 | 53,111 |
The results for the six months to 30 June 2022 and 30 June 2021 constitute nonstatutory accounts within the meaning of Section 434 of the Companies Act 2006. The latest published accounts which have been delivered to the Registrar of Companies are for the year ended 31 December 2021; the report of the Auditors thereon was unqualified and did not contain a statement under section 498 of the Companies Act 2006. The condensed financial statements shown for the year end 31 December 2021 are an extract from those accounts.
These condensed financial statements have been prepared on a going concern basis in accordance with the Companies Act 2006, Interim Financial Reporting (FRS 104) and the revised Statement of Recommended Practice "Financial Statements of Investment Trust Companies and Venture Capital Trusts" (SORP), issued by the AIC in April 2021.
The accounting policies applied for the condensed set of financial statements are set out in the Company's annual report for the year ended 31 December 2021.
The presentation of the financial statements in accordance with accounting standards requires the Board to make judgements, estimates and assumptions that affect the accounting policies and reported amounts of assets, liabilities, income and expenses. Estimates and judgements are continually evaluated and are based on perceived risks, historical experience, expectations of plausible future events and other factors. Actual results may differ from these estimates.
The area requiring the most significant judgement and estimation in the preparation of the financial statements is accounting for the value of unquoted investments.
The policy for valuation of unquoted securities is set out in note 8 and further information on Board procedures is contained in the Report of the Audit Committee and note 26(d) of the Report and Accounts as at 31 December 2021. The choice to only apply cash flows in the roll forward is a judgment made each year for the indirect investments. Material judgements were applied to the valuation of the Company's direct investment, Inflexion Strategic Partners. This investment was valued using the earnings method multipled by a comparable quoted company multiple (where the judgement of which comparable companies to select and what discounts to apply are subjective). The fair value of unquoted (Level 3) investments, as disclosed in note 8, represented 12.2% of total investments at 30 June 2022. Under foreseeable market conditions the collective value of such investments may rise or fall in the short term by more than 25%, in the opinion of the Directors. A fall of 25% in the value of the unlisted (Level 3) portfolio at the half-year would equate to £148m or 3.3% of net assets and a similar percentage rise should be construed accordingly.
| Income comprises | Half-year ended 30 June 2022 £'000s |
Half-year ended 30 June 2021 £'000s |
Year ended 31 December 2021 £'000s |
|---|---|---|---|
| UK dividends | 4,649 | 4,135 | 8,059 |
| Overseas dividends | 45,988 | 36,119 | 69,559 |
| Interest on short-term deposits and other income |
196 | 142 | 11 |
| Income | 50,833 | 40,396 | 77,629 |
Included within income is £1.0m (30 June 2021: £0.6m; 31 December 2021: £1.4m) of special dividends classified as revenue in nature.
The value of special dividends treated as capital in nature is £0.1m (30 June 2021: £0.0m; 31 December 2021: £1.5m).
| Half-year | Year | ||
|---|---|---|---|
| ended | ended | ended | |
| 30 June | 30 June | 31 December | |
| 2022 £'000s |
2021 £'000s |
2021 £'000s |
|
| Fees and other expenses | 11,632 | 11,181 | 23,297 |
| Interest payable and similar charges | 7,006 | 4,884 | 11,113 |
| Total | 18,638 | 16,065 | 34,410 |
| Fees and other expenses comprise: | |||
| Allocated to Revenue Account | |||
| Management fees payable directly to the Manager* |
2,252 | 2,391 | 4,935 |
| Other expenses | 2,596 | 1,584 | 3,500 |
| 4,848 | 3,975 | 8,435 | |
| Allocated to Capital Account | |||
| Management fees payable directly to the Manager* |
6,755 | 7,172 | 14,805 |
| Other expenses | 29 | 34 | 57 |
| 6,784 | 7,206 | 14,862 | |
| Interest payable and similar charges comprise: |
|||
| Allocated to Revenue Account | 1,751 | 1,221 | 2,778 |
| Allocated to Capital Account | 5,255 | 3,663 | 8,335 |
*including reimbursement in respect of services provided by sub-managers.
As detailed in the Report and Accounts to 31 December 2021, with effect from 1 January 2022, the Manager's remuneration is based on a fee of 0.325% (0.35% up to 31 December 2021) per annum of the market capitalisation of the Company up to £3.0 billion, 0.30% (0.30% up to 31 December 2021) between £3.0 and £4.0 billion, and 0.25% (0.25% up to 31 December 2021) above £4.0 billion calculated at each month end date on a pro-rata basis. The fee is adjusted for fees earned by the Manager in respect of investment holdings managed or advised by the Manager. Variable fees payable in respect of third party sub-managers are also reimbursed. The services provided by the Manager remain unchanged from those disclosed within the accounts for the year ended 31 December 2021. The level of variable fees payable in respect of third party sub-managers and private equity managers remain unchanged since the year end.
The taxation charge of £5,924,000 (30 June 2021: £3,768,000 and 31 December 2021: £7,878,000) relates to irrecoverable overseas taxation and Indian tax on capital gains.
Net return per ordinary share attributable to ordinary shareholders reflects the overall performance of the Company in the period. Net revenue recognised in the first six months is not indicative of the total likely to be received in the full accounting year.
| Half-year | Half-year | Year | |
|---|---|---|---|
| ended | ended | ended | |
| 30 June | 30 June | 31 December | |
| 2022 | 2021 | 2021 | |
| £'000s | £'000s | £'000s | |
| Revenue return | 39,196 | 31,354 | 58,500 |
| Capital return | (669,333) | 484,884 | 860,778 |
| Total return | (630,137) | 516,238 | 919,278 |
| Weighted average ordinary shares in issue, excluding treasury shares (see note 11) |
524,268,795 | 534,639,847 | 532,196,543 |
| Half-year ended 30 June 2022 pence |
Half-year ended 30 June 2021 pence |
Year ended 31 December 2021 pence |
|
|---|---|---|---|
| Revenue return | 7.48 | 5.86 | 10.99 |
| Capital return | (127.67) | 90.69 | 161.74 |
| Total return | (120.19) | 96.55 | 172.73 |
| Dividends paid on ordinary shares |
Register Date Payment date | Half-year ended 30 June 2022 £'000s |
Half-year ended 30 June 2021 £'000s |
Year ended 31 December 2021 £'000s |
|
|---|---|---|---|---|---|
| 2020 Third interim of 2.90p |
3-Jan-2021 | 1-Feb-2021 | – | 15,563 | 15,563 |
| 2020 Final of 3.40p | 16-Apr-2021 13-May-2021 | – | 18,146 | 18,146 | |
| 2021 First interim of 3.00p |
16-Jul-2021 | 2-Aug-2021 | – | – | 15,967 |
| 2021 Second interim of 3.00p |
8-Oct-2021 | 1-Nov-2021 | – | – | 15,902 |
| 2021 Third interim of 3.00p |
7-Jan-2022 | 1-Feb-2022 | 15,804 | – | – |
| 2021 Final of 3.80p | 8-Apr-2022 10-May-2022 | 19,929 | – | – | |
| 2022 First interim of 3.20p |
1-Jul-2022 | 1-Aug-2022 | 16,649 | – | – |
| 52,382 | 33,709 | 65,578 |
The Directors have declared a first interim dividend in respect of the year ending 31 December 2022 of 3.20p per share, payable on 1 August 2022 to all shareholders on the register at close of business on 1 July 2022. The amount of this dividend will be £16,649,000 based on 520,294,833 shares in issue at 30 June 2022. This amount has been accrued in the results for the half-year ended 30 June 2022 as the ex-dividend date was 30 June 2022.
The Company's Investments as disclosed in the balance sheet are valued at fair value.
The fair value as at the reporting date has been estimated using the following fair value hierarchy:
Level 1 includes investments and derivatives listed on any recognised stock exchange or quoted on the AIM market in the UK and quoted open-ended funds.
Level 2 includes investments for which the quoted price has been suspended, forward exchange contracts and other derivative instruments.
Level 3 includes investments in private companies or securities, whether invested in directly or through pooled Private Equity vehicles, for which observable market data is not specifically available.
The analysis of the valuation basis for financial instruments based on the hierarchy is as follows:
| As at 30 June 2022* £'000s |
As at 30 June 2021* £'000s |
As at 31 December 2021* £'000s |
|
|---|---|---|---|
| Level 1 | 4,259,149 | 4,951,479 | 5,259,951 |
| Level 3 | 591,511 | 445,889 | 519,172 |
| Total valuation of investments | 4,850,660 | 5,397,368 | 5,779,123 |
With respect specifically to investments in Private Equity, whether through funds or partnerships, the Directors rely on the latest available unaudited quarterly valuations of the underlying unlisted investments as supplied by the investment advisers or managers of those funds or partnerships. The Directors regularly review the principles applied by the managers to those valuations to ensure they are in compliance with the principal accounting policies as stated in the year end report and accounts.
No investments held at 30 June 2022, 30 June 2021 or 31 December 2021 were valued in accordance with level 2.
Derivative instruments included forward exchange contracts with a net unrealised capital loss of £1.6m as at 30 June 2022 (30 June 2021: unrealised capital loss of £1.2m and 31 December 2021: unrealised capital loss of £4.8m).
| 30 June 2022 £'000s |
30 June 2021 £'000s |
31 December 2021 £'000s |
|
|---|---|---|---|
| Loans falling due within one year | 61,981 | – | 110,452 |
| Loans falling due after more than one year | 580,155 | 501,863 | 439,263 |
| Debenture falling due after more than one year | 575 | 575 | 575 |
| Comprising: | |||
| Sterling denominated loan, falling due within one year |
– | – | £50m |
| Euro denominated loan, falling due within one year |
€72m | – | €72m |
| Sterling denominated loan, falling due after more one year |
£544m | £404m | £404m |
| Euro denominated loan, falling due after more than one year |
€42m | €114m | €42m |
| 4.25% perpetual debenture stock | £0.575m | £0.575m | £0.575m |
In March 2022 the Company issued fixed rate senior unsecured notes in tranches of £50 million, £45 million and £45 million expiring in March 2037, March 2056 and March 2061 respectively. Interest rates applying to the notes are commercially competitive and fixed until the expiry dates.
| 30 June 2022 £'000s |
30 June 2021 £'000s |
31 December 2021 £'000s |
|
|---|---|---|---|
| Cost of ordinary shares repurchased | 1,325 | 3,205 | 784 |
| Investment creditors | 8,346 | 37,955 | 42 |
| Management fees payable to the Manager | 1,726 | 2,173 | 2,241 |
| Foreign exchange contracts | 1,559 | 1,205 | 4,806 |
| Dividend payable | 16,649 | - | - |
| Other accrued expenses | 2,160 | 1,140 | 1,404 |
| 31,765 | 45,678 | 9,277 |
| Equity share capital | Shares held in Shares entitled treasury to dividend Number Number |
Total shares in issue Number |
Total shares in issue nominal £'000s |
|
|---|---|---|---|---|
| Ordinary shares of 25p each | ||||
| Balance at 31 December 2021 | 35,035,876 | 526,783,140 | 561,819,016 | 140,455 |
| Shares repurchased by the Company and held in treasury |
6,488,307 | (6,488,307) | – | – |
| Balance at 30 June 2022 | 41,524,183 520,294,833 | 561,819,016 | 140,455 |
6,488,307 shares were repurchased during the period at a cost of £54,352,000. Shares held in treasury have no voting rights and no right to dividend distributions and are excluded from the calculations of earnings per share and net asset value per share.
| 6 months to 30 June 2022 |
6 months to 30 June 2021 |
Year ended 31 December 2021 |
|
|---|---|---|---|
| Net asset value per share – pence | 873.36 | 931.59 | 1,002.49 |
| Net assets attributable at end of period – £'000s |
4,544,063 | 4,960,030 | 5,280,934 |
| Ordinary shares of 25p in issue at end of period excluding shares held in treasury – number |
520,294,833 | 532,428,251 | 526,783,140 |
Net asset value per share (with debenture stock and long-term loans at market value) at 30 June 2022 was 892.77p (30 June 2021: 927.41p and 31 December 2021: 998.72p). The market value of debenture stock at 30 June 2022 was £429,000 (30 June 2021 and 31 December 2021: £429,000). The market value of the long-term loans at 30 June 2022 was £479,338,000 (30 June 2021: £524,243,000 and 31 December 2021: £458,896,000) based on the equivalent benchmark gilts or relevant commercially available current debt.
| Half-year | Half-year | Year | |
|---|---|---|---|
| ended 30 June |
ended 30 June |
ended 31 December |
|
| 2022 | 2021 | 2021 | |
| £'000s | £'000s | £'000s | |
| Net return on ordinary activities before taxation | (624,213) | 520,006 | 927,156 |
| Adjust for non-cash flow items, dividend income and interest expense: |
|||
| Losses/(gains) on Investments | 649,585 | (487,969) | (879,862) |
| Exchange losses/(gains) | 6,823 | (7,706) | (4,075) |
| Non-operating expenses of a capital nature | 29 | 34 | 57 |
| (Increase)/decrease in other debtors | (112) | 24 | 60 |
| Decrease in creditors | (635) | (341) | (61) |
| Dividends receivable | (50,637) | (40,254) | (77,618) |
| Interest payable | 7,006 | 4,884 | 11,113 |
| Tax on overseas income and Indian Capital Gains Tax | (6,569) | (434) | (4,346) |
| 605,490 | (531,762) | (954,732) | |
| Cash flows from operating activities (before | |||
| dividends received and interest paid) | (18,723) | (11,756) | (27,576) |
| Forward | ||||||
|---|---|---|---|---|---|---|
| Cash £'000s |
Short-term loans £'000s |
Long-term loans £'000s |
Debenture £'000s |
foreign exchange £'000s |
Total £'000s |
|
| Opening net debt as at 31 December 2021 |
53,111 (110,452) (439,263) | (575) | (4,806) (501,985) | |||
| Cash-flows: | ||||||
| Drawdown of loans | – | – (140,000) | – | – (140,000) | ||
| Repayment of bank loans |
– | 50,000 | – | – | – | 50,000 |
| Net movement in cash and cash equivalents |
306,828 | – | – | – | – | 306,828 |
| Non-cash: | ||||||
| Effect of foreign exchange movements |
(7,649) | (1,529) | (892) | – | 3,247 | (6,823) |
| Closing net debt as at 30 June 2022 |
352,290 | (61,981) (580,155) | (575) | (1,559) | (291,980) |
In assessing the going concern basis of accounting the Directors have had regard to the guidance issued by the Financial Reporting Council. They have also considered the Company's objective, strategy and policy; current cash position; the availability of loan finance; compliance with all financial loan and private placement covenants; and the operational resilience of the Company and its service providers. It is recognised that the Company is mainly invested in readily realisable, globally listed securities that can be sold, if necessary, to repay indebtedness.
Based on this information and their knowledge and experience of the Company's portfolio and stockmarkets, the Directors believe that the Company has the ability to meet its financial obligations as they fall due for a period of at least twelve months from the date of approval of these financial statements. Accordingly, these financial statements have been prepared on a going concern basis.
By order of the Board Columbia Threadneedle Investment Business Limited Company Secretary Exchange House Primrose Street London EC2A 2NY
22 July 2022
The Company's principal risks and uncertainties are described in detail under the heading "Principal risks and future prospects" within the strategic report in the Company's annual report for the year ended 31 December 2021. They include: failure to access the targeted market or meet investor needs or expectations; inappropriate asset allocation, sector and stock selection, currency exposure and use of gearing and derivatives may lead to investment underperformance; failure of the management company to continue to operate effectively resulting from
inadequate systems or resources or through loss of key staff; COVID-19 and the implementation of hybrid working arrangements and increased sophistication of cyber threats have heightened the risk of loss through errors, fraud or control failures at service providers or loss of data through business continuity failure.
In the view of the Board, there have not been any material changes to the fundamental nature of these risks and they are applicable to the remainder of the financial year.
In accordance with Chapter 4 of the Disclosure Guidance and Transparency Rules, the Directors confirm that to the best of their knowledge:
• the Statement of Principal and Emerging Risks and Uncertainties shown on the previous page is a fair review of the principal risks and uncertainties for the remainder of the financial year; and
• the half-year report includes a fair review of the related party transactions that have taken place in the first six months of the financial year.
On behalf of the Board Beatrice Hollond Chairman 22 July 2022
One of the most convenient ways to invest in F&C Investment Trust PLC is through one of the savings plans run by Columbia Threadneedle Investments.
You can use your ISA allowance to make an annual tax efficient investment of up to £20,000 for the current tax year with a lump sum from £100 or regular savings from £25 a month. You can also transfer any existing ISAs to us whilst maintaining the tax benefits.
If your child already has a CTF, you can invest up to £9,000 per birthday year, from £100 lump sum or £25 a month. CTFs with other providers can be transferred to Columbia Threadneedle Investments.
CT General Investment Account (GIA) This is a flexible way to invest in our range of Investment Trusts. There are no maximum contributions, and investments can be made from £100 lump sum or £25
CT Junior Investment Account (JIA) This is a flexible way to save for a child in our range of Investment Trusts. There are no maximum contributions, and the plan can easily be set up under bare trust (where the child is noted as the beneficial owner) or kept in your name if you wish to retain control over the investment. Investments can be made from a £100 lump sum or £25 a month per account. You can also make additional lump sum top-ups at any time from £100 per
A tax efficient way to invest up to £9,000 per tax year for a child. Contributions start from £100 lump sum or £25 a month. JISAs or CTFs with other providers can be transferred to Columbia Threadneedle Investments.
For those aged 18-39, a LISA could help towards purchasing your first home or retirement in later life. Invest up to £4,000 for the current tax year and receive a 25% Government bonus up to £1,000 per year. Invest with a lump sum from £100 or regular savings from £25 a month.
Annual management charges and other charges apply according to the type of plan.
JISA/JIA/CTF: £25+VAT
Annual account charge ISA/LISA: £60+VAT GIA: £40+VAT
account.
a month.
You can pay the annual charge from your account, or by direct debit (in addition to any annual subscription limits).
Half-Year Report 2022 34
£12 per fund (reduced to £0 for deals placed through the online Columbia Threadneedle Investor Portal) for ISA/GIA/LISA/JIA and JISA. There are no dealing charges on a CTF.
Dealing charges apply when shares are bought or sold but not on the reinvestment of dividends or the investment of monthly direct debits. Government stamp duty of 0.5% also applies on the purchase of shares (where applicable).
The value of investments can go down as well as up and you may not get back your original investment. Tax benefits depend on your individual circumstances and tax allowances and rules may change. Please ensure you have read the full Terms and Conditions, Privacy Policy and relevant Key
Call: 0800 136 420**
(8:30am – 5:30pm, weekdays)
Email: [email protected]
Call: 0345 600 3030**
(9:00am – 5:00pm, weekdays)
Email: [email protected]
Post: Columbia Threadneedle Management Limited, PO Box 11114, Chelmsford CM99 2DG
You can also invest in the trust through online dealing platforms for private investors that offer share dealing and ISAs. Companies include: Barclays Stockbrokers, EQi, Halifax, Hargreaves Lansdown, HSBC, Interactive Investor, LLoyds Bank, The Share Centre.
*The CTF and JISA accounts are opened in the child's name and they can have access to the account at age 18. **Calls may be recorded or monitored for training and quality purposes.
Features documents before investing. For regulatory purposes, please ensure you have read the Pre-sales Cost & Charges disclosure related to the product you are applying for, and the relevant Key Information Documents (KIDs) for the investment trusts you want to
To open a new Columbia Threadneedle Investments plan, apply online at ctinvest.co.uk Online applications are not available if you are transferring an existing plan with another provider to Columbia Threadneedle Investments, or if you are applying for a new plan in more than one name but paper applications are available at ctinvest.co.uk/documents or by contacting Columbia Threadneedle Investments.
invest into. How to Invest
0345 600 3030, 9.00am – 5.00pm, weekdays, calls may be recorded or monitored for training and quality purposes.
© 2022 Columbia Threadneedle Investments. Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies. Financial promotions are issued for marketing and information purposes by Columbia Threadneedle Management Limited, authorised and regulated in the UK by the Financial Conduct Authority. 195600 (06/22) UK
The Company's report and accounts are available on the Internet at fandc.com. Printed copies may be obtained from the Company's registered office, Exchange House, Primrose Street, London EC2A 2NY
If you have trouble reading small print, please let us know. We can provide literature in alternative formats, for example large print or on audiotape. Please call 0345 600 3030**.
Fraudsters use persuasive and high-pressure tactics to lure investors into scams. They may offer to sell shares that turn out to be worthless or non-existent, or to buy shares at an inflated price in return for an upfront payment.
If you receive unsolicited investment advice or requests:
If you are approached by fraudsters please tell the FCA by using the share fraud reporting form at fca.org.uk/scams where you can find out more about investment scams. You can also call the FCA Consumer Helpline on 0800 111 6768. If you have already paid money to share fraudsters you should contact Action Fraud on 0300 123 2040.
**Calls may be recorded or monitored for training and quality purposes.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.